Patrick Lamy, Senior VP, Commercial Strategy at Akero Therapeutics, Inc. (AKRO), sold 2,000 shares at $52.88 ($106K) on 2025-07-01, disclosed to the SEC on 2025-07-03.
Scheduled sale ($106k) by Senior VP, Commercial Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AKRO | SELL | 2025-06-12 | $50K | — | Filing → |
| AKRO | SELL | 2025-06-04 | $201K | — | Filing → |
| AKRO | SELL | 2025-05-23 | $200K | — | Filing → |